Skip to main content
Premium Trial:

Request an Annual Quote

Fasteris Becomes First European Certified Service Provider for Agilent's Target-Enrichment System

Premium

Agilent Technologies said this week that sequencing service provider Fasteris has become the first European certified -service provider for Agilent's SureSelect Target Enrichment System.

SureSelect, an in-solution target enrichment method, was introduced in February and allows sequencing experiments to focus on specific genomic regions, rather than the entire genome.

Geneva, Switzerland-based Fasteris reached CSP status after it demonstrated "a high level of proficiency" using the SureSelect system with the Illumina Genome Analyzer.

"We have been impressed by the SureSelect technology with its high proportion of reads on target and resulting reduction in downstream sequencing costs on the Illumina Genome Analyzer," Fasteris founder and CEO Laurent Farinelli said in a statement.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.